216 related articles for article (PubMed ID: 31497999)
21. Causal mediation analysis with a latent mediator.
Albert JM; Geng C; Nelson S
Biom J; 2016 May; 58(3):535-48. PubMed ID: 26363769
[TBL] [Abstract][Full Text] [Related]
22. Mediation analysis with multiple mediators under unmeasured mediator-outcome confounding.
Wickramarachchi DS; Lim LHM; Sun B
Stat Med; 2023 Feb; 42(4):422-432. PubMed ID: 36502820
[TBL] [Abstract][Full Text] [Related]
23. A weighting approach to causal effects and additive interaction in case-control studies: marginal structural linear odds models.
VanderWeele TJ; Vansteelandt S
Am J Epidemiol; 2011 Nov; 174(10):1197-203. PubMed ID: 22058231
[TBL] [Abstract][Full Text] [Related]
24. Adjusting for Baseline Measurements of the Mediators and Outcome as a First Step Toward Eliminating Confounding Biases in Mediation Analysis.
Loh WW; Ren D
Perspect Psychol Sci; 2023 Sep; 18(5):1254-1266. PubMed ID: 36749872
[TBL] [Abstract][Full Text] [Related]
25. Simulation-based sensitivity analysis for causal mediation studies.
Qin X; Yang F
Psychol Methods; 2022 Dec; 27(6):1000-1013. PubMed ID: 34914470
[TBL] [Abstract][Full Text] [Related]
26. A Comparison of Agent-Based Models and the Parametric G-Formula for Causal Inference.
Murray EJ; Robins JM; Seage GR; Freedberg KA; Hernán MA
Am J Epidemiol; 2017 Jul; 186(2):131-142. PubMed ID: 28838064
[TBL] [Abstract][Full Text] [Related]
27. Misspecification of confounder-exposure and confounder-outcome associations leads to bias in effect estimates.
Schuster NA; Rijnhart JJM; Bosman LC; Twisk JWR; Klausch T; Heymans MW
BMC Med Res Methodol; 2023 Jan; 23(1):11. PubMed ID: 36635655
[TBL] [Abstract][Full Text] [Related]
28. Insights into the Cross-world Independence Assumption of Causal Mediation Analysis.
Andrews RM; Didelez V
Epidemiology; 2021 Mar; 32(2):209-219. PubMed ID: 33512846
[TBL] [Abstract][Full Text] [Related]
29. Genotypic resistance to zidovudine as a predictor of failure of subsequent therapy with human immunodeficiency virus type-1 nucleoside reverse-transcriptase inhibitors.
Venturi G; Romano L; Catucci M; Riccio ML; De Milito A; Gonnelli A; Rubino M; Valensin PE; Zazzi M
Eur J Clin Microbiol Infect Dis; 1999 Apr; 18(4):274-82. PubMed ID: 10385016
[TBL] [Abstract][Full Text] [Related]
30. Adjustment for unmeasured confounding through informative priors for the confounder-outcome relation.
Groenwold RHH; Shofty I; Miočević M; van Smeden M; Klugkist I
BMC Med Res Methodol; 2018 Dec; 18(1):174. PubMed ID: 30577773
[TBL] [Abstract][Full Text] [Related]
31. Mediational E-values: Approximate Sensitivity Analysis for Unmeasured Mediator-Outcome Confounding.
Smith LH; VanderWeele TJ
Epidemiology; 2019 Nov; 30(6):835-837. PubMed ID: 31348008
[TBL] [Abstract][Full Text] [Related]
32. Assessing the impact of unmeasured confounders for credible and reliable real-world evidence.
Zhang X; Stamey JD; Mathur MB
Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1219-1227. PubMed ID: 32929830
[TBL] [Abstract][Full Text] [Related]
33. How unmeasured confounding in a competing risks setting can affect treatment effect estimates in observational studies.
Barrowman MA; Peek N; Lambie M; Martin GP; Sperrin M
BMC Med Res Methodol; 2019 Jul; 19(1):166. PubMed ID: 31366331
[TBL] [Abstract][Full Text] [Related]
34. Sensitivity analysis: distributional assumptions and confounding assumptions.
Vanderweele TJ
Biometrics; 2008 Jun; 64(2):645-9. PubMed ID: 18482060
[TBL] [Abstract][Full Text] [Related]
35. Joint mixed-effects models for causal inference with longitudinal data.
Shardell M; Ferrucci L
Stat Med; 2018 Feb; 37(5):829-846. PubMed ID: 29205454
[TBL] [Abstract][Full Text] [Related]
36. Bayesian data fusion: Probabilistic sensitivity analysis for unmeasured confounding using informative priors based on secondary data.
Comment L; Coull BA; Zigler C; Valeri L
Biometrics; 2022 Jun; 78(2):730-741. PubMed ID: 33527348
[TBL] [Abstract][Full Text] [Related]
37. Controlling for continuous confounders in epidemiologic research.
Brenner H; Blettner M
Epidemiology; 1997 Jul; 8(4):429-34. PubMed ID: 9209859
[TBL] [Abstract][Full Text] [Related]
38. Pragmatic trials: ignoring a mediator and adjusting for confounding.
Pericleous P
BMC Res Notes; 2019 Mar; 12(1):156. PubMed ID: 30894221
[TBL] [Abstract][Full Text] [Related]
39. Measurement error, time lag, unmeasured confounding: Considerations for longitudinal estimation of the effect of a mediator in randomised clinical trials.
Goldsmith KA; Chalder T; White PD; Sharpe M; Pickles A
Stat Methods Med Res; 2018 Jun; 27(6):1615-1633. PubMed ID: 27647810
[TBL] [Abstract][Full Text] [Related]
40. Distribution-free mediation analysis for nonlinear models with confounding.
Albert JM
Epidemiology; 2012 Nov; 23(6):879-88. PubMed ID: 23007042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
